PG
GSK icon

PEAK6 Group’s GSK GSK Stock Holding History

PEAK6 Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-170,371
Closed -$7.93M – 4546
2017
Q4 		$7.55M Buy
170,371
+137,265
+415% +$6.34M 0.04% 608
2017
Q3 		$1.68M Buy
+33,106
New +$1.68M 0.01% 1529
2015
Q4 		– Sell
-111,146
Closed -$5.67M – 4953
2015
Q3 		$5.34M Buy
111,146
+90,674
+443% +$4.72M 0.03% 844
2015
Q2 		$1.07M Buy
+20,472
New +$1.15M 0.01% 2018
2015
Q1 		– Sell
-17,454
Closed -$1M – 4920
2014
Q4 		$932K Buy
17,454
+10,679
+158% +$597K 0.01% 2008
2014
Q3 		$389K Buy
+6,775
New +$415K ﹤0.01% 2708
2013
Q4 		– Sell
-1,824
Closed -$57.1K – 5078
2013
Q3 		$57.1K Sell
1,824
-22,970
-93% -$1.48M ﹤0.01% 4476
2013
Q2 		$1.55K Buy
+24,794
New +$1.57M 0.01% 1760

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PEAK6 Group's GSK Position: Q1 2018 in Review

PEAK6 Group sold out of GSK (GSK) in Q1 2018, closing a stake of 170,371 shares — an estimated $7.93M sold.

PEAK6 Group first reported a position in GSK in Q2 2013 and held it in 8 quarters. The position peaked at $7.55M in Q4 2017. 778 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

  • PEAK6 Group reported no remaining GSK position as of Q1 2018 after selling out during the quarter.
  • PEAK6 Group sold 170,371 GSK shares in Q1 2018, an estimated $7.93M.
  • PEAK6 Group first reported a position in GSK in Q2 2013 and held it in 8 quarters.
  • PEAK6 Group's GSK position peaked at $7.55M in Q4 2017.
  • 778 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.